Histone lysine methyltransferases, namely KMT2D, SETDB1, and EZH2, are the large classes of enzymes that catalyze site-specific methylation of lysine residues on histones and other proteins, playing significant functions to control transcription, chromatin architecture, cellular differentiation, and melanoma progression (Fig. 2). The gene discussed is EZH2; the disease is melanoma.